These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma. Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535 [TBL] [Abstract][Full Text] [Related]
5. Ocular toxicity study of trypan blue injected into the vitreous cavity of rabbit eyes. Veckeneer M; van Overdam K; Monzer J; Kobuch K; van Marle W; Spekreijse H; van Meurs J Graefes Arch Clin Exp Ophthalmol; 2001 Sep; 239(9):698-704. PubMed ID: 11688671 [TBL] [Abstract][Full Text] [Related]
7. Antibody Format and Serum Disposition Govern Ocular Pharmacokinetics of Intravenously Administered Protein Therapeutics. Shivva V; Boswell CA; Rafidi H; Kelley RF; Kamath AV; Crowell SR Front Pharmacol; 2021; 12():601569. PubMed ID: 34025395 [TBL] [Abstract][Full Text] [Related]
8. Ocular tissue distribution and pharmacokinetic study of a small 13kDa domain antibody after intravitreal, subconjuctival and eye drop administration in rabbits. Gough G; Szapacs M; Shah T; Clements P; Struble C; Wilson R Exp Eye Res; 2018 Feb; 167():14-17. PubMed ID: 29074387 [TBL] [Abstract][Full Text] [Related]
9. Intravitreal sustained-release cyclosporine in the treatment of experimental uveitis. Jaffe GJ; Yang CS; Wang XC; Cousins SW; Gallemore RP; Ashton P Ophthalmology; 1998 Jan; 105(1):46-56. PubMed ID: 9442778 [TBL] [Abstract][Full Text] [Related]
10. Binding to Ocular Albumin as a Half-Life Extension Principle for Intravitreally Injected Drugs: Evidence from Mechanistic Rat and Rabbit Studies. Fuchs H; Igney F J Ocul Pharmacol Ther; 2017 Mar; 33(2):115-122. PubMed ID: 28055308 [TBL] [Abstract][Full Text] [Related]
11. Distribution and metabolism of intravitreal cidofovir and cyclic HPMPC in rabbits. Cundy KC; Lynch G; Shaw JP; Hitchcock MJ; Lee WA Curr Eye Res; 1996 May; 15(5):569-76. PubMed ID: 8670758 [TBL] [Abstract][Full Text] [Related]
12. Intravitreal sustained-release dexamethasone device in the treatment of experimental uveitis. Cheng CK; Berger AS; Pearson PA; Ashton P; Jaffe GJ Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):442-53. PubMed ID: 7843913 [TBL] [Abstract][Full Text] [Related]
14. Effect of intravitreal triamcinolone acetonide on susceptibility to experimental bacterial endophthalmitis and subsequent response to treatment. Bucher RS; Hall E; Reed DM; Richards JE; Johnson MW; Zacks DN Arch Ophthalmol; 2005 May; 123(5):649-53. PubMed ID: 15883284 [TBL] [Abstract][Full Text] [Related]
15. [Intraocular implantation of cyclosporine A drug delivery system in the treatment of experimental uveitis]. Dong XG; Xu YM; Yuan GQ; Shi WY; Xie LX; Wang SG Zhonghua Yan Ke Za Zhi; 2005 Jul; 41(7):636-41. PubMed ID: 16080900 [TBL] [Abstract][Full Text] [Related]